VOLTATTORNI, Carla
 Distribuzione geografica
Continente #
NA - Nord America 8.798
EU - Europa 5.847
AS - Asia 4.939
SA - Sud America 549
Continente sconosciuto - Info sul continente non disponibili 130
AF - Africa 88
OC - Oceania 11
Totale 20.362
Nazione #
US - Stati Uniti d'America 8.510
RU - Federazione Russa 2.009
SG - Singapore 1.955
CN - Cina 1.739
GB - Regno Unito 1.635
BR - Brasile 434
HK - Hong Kong 405
IT - Italia 390
FR - Francia 341
VN - Vietnam 337
SE - Svezia 335
DE - Germania 309
FI - Finlandia 308
IE - Irlanda 226
CA - Canada 153
KR - Corea 148
UA - Ucraina 133
IN - India 64
BD - Bangladesh 63
JP - Giappone 58
AR - Argentina 41
MX - Messico 35
TR - Turchia 35
NL - Olanda 27
BE - Belgio 25
ID - Indonesia 24
CR - Costa Rica 22
ZA - Sudafrica 22
IQ - Iraq 21
PL - Polonia 20
EC - Ecuador 19
NG - Nigeria 18
SA - Arabia Saudita 15
CL - Cile 14
ES - Italia 14
SV - El Salvador 14
CO - Colombia 12
GT - Guatemala 12
PK - Pakistan 12
UZ - Uzbekistan 12
PR - Porto Rico 11
LT - Lituania 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
AU - Australia 9
CW - ???statistics.table.value.countryCode.CW??? 9
HN - Honduras 9
NI - Nicaragua 9
VE - Venezuela 9
UY - Uruguay 8
BG - Bulgaria 7
EG - Egitto 7
JM - Giamaica 7
CH - Svizzera 6
GR - Grecia 6
IL - Israele 6
LV - Lettonia 6
PH - Filippine 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
GP - Guadalupe 5
RO - Romania 5
SC - Seychelles 5
TN - Tunisia 5
KE - Kenya 4
MY - Malesia 4
PT - Portogallo 4
AZ - Azerbaigian 3
BH - Bahrain 3
EE - Estonia 3
EU - Europa 3
GA - Gabon 3
JO - Giordania 3
PA - Panama 3
PE - Perù 3
TG - Togo 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
LU - Lussemburgo 2
MD - Moldavia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
Totale 20.227
Città #
Southend 1.443
Singapore 1.067
Jacksonville 1.063
Ashburn 1.022
San Jose 841
Moscow 630
Chandler 621
Dallas 565
Woodbridge 565
Hong Kong 399
Ann Arbor 371
Houston 299
Beijing 237
Dublin 224
Verona 214
The Dalles 189
Council Bluffs 183
Jinan 150
Nanjing 138
Wilmington 131
Lawrence 128
Princeton 128
Shenyang 126
Ho Chi Minh City 121
Los Angeles 116
New York 100
Hanoi 91
Santa Clara 82
Tianjin 77
Buffalo 73
Sindelfingen 73
Hebei 72
Changsha 67
Annandale 63
Helsinki 63
Boardman 62
Columbus 53
Ningbo 53
Tokyo 52
Nanchang 51
Milan 50
São Paulo 49
Haikou 47
Zhengzhou 44
Hangzhou 41
Munich 40
Philadelphia 38
Taiyuan 36
Toronto 36
Montreal 35
Guangzhou 33
Brooklyn 32
Jiaxing 32
San Francisco 32
Taizhou 32
Las Vegas 31
Chicago 29
Lancaster 29
Lanzhou 29
Orem 27
Redondo Beach 27
Fuzhou 25
Seattle 25
Norwalk 24
London 22
Boston 21
Brussels 21
Chennai 21
Phoenix 21
Belo Horizonte 19
Frankfurt am Main 19
Warsaw 19
Johannesburg 18
Seoul 18
Denver 16
Falls Church 16
Redmond 16
San José 16
Abuja 15
Haiphong 14
Stockholm 14
Atlanta 13
Amsterdam 12
Auburn Hills 12
Detroit 12
Jakarta 12
Mexico City 12
Rio de Janeiro 11
San Salvador 11
Tashkent 11
Da Nang 10
Manchester 10
Rome 9
Willemstad 9
Clearwater 8
Dearborn 8
Fairfield 8
Kent 8
Managua 8
Quito 8
Totale 13.324
Nome #
Dimerization and Folding Processes of Treponema denticola Cystalysin: The Role of Pyridoxal 5'-Phosphate 301
Holo-and apocystalysin from Treponema denticola: two different conformations 286
Pyridoxal 5’-Phosphate Enzymes as Targets for Therapeutic Agents 281
Biochemical and computational approaches to improve the clinical treatment of Dopa decarboxylase-related diseases: an overview 277
A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications 248
Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications 243
S250F variant associated with aromatic amino acid decarboxylase deficiency: molecular defects and intracellular rescue by pyridoxine 234
Affinity labelling of pig kidney Dopa decarboxylase with N-(bromoacetyl)pyridoxamine 5'-phosphate. Modification of an active site cysteine 232
Dopa decarboxylase exhibits low pH half-transaminase and high pH oxidative deaminase activities toward serotonin (5-hydroxytryptamine) 231
An engineered folded PLP-bound monomer of Treponema denticola cystalysin reveals the effect of the dimeric structure on the catalytic properties of the enzyme 215
Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with Primary Hyperoxaluria Type I. 212
Construction, purification and characterization of untagged human liver alanine-glyoxylate aminotransferase expressed in Escherichia coli 211
Folding defects leading to primary hyperoxaluria 208
A quinonoid is an intermediate of oxidative deamination reaction catalyzed by Dopa decarboxylase 206
Crystal structure of the S187F variant of human liver alanine: Aminotransferase associated with primary hyperoxaluria type I and its functional implications 206
Human liver peroxisomal alanine:glyoxylate aminotransferase: Different stability under chemical stress of the major allele, the minor allele, and its pathogenic G170R variant. 205
Interaction of Human Dopa Decarboxylase with L-Dopa: Spectroscopic and Kinetic Studies as a Function of pH 203
Human liver peroxisomal alanine:glyoxylate aminotransferase: Characterization of the two allelic forms and their pathogenic variants. 201
An essential arginine residue at the binding site of pig kidney 3,4-dihydroxyphenylalanine decarboxylase 199
Chemical modification of pig kidney 3,4-dihydroxyphenylalanine decarboxylase with diethyl pyrocarbonate. Evidence for an essential histidyl residue 198
Cysteine 180 Is a Redox Sensor Modulating the Activity of Human Pyridoxal 5'-Phosphate Histidine Decarboxylase 195
New variants of AADC deficiency expand the knowledge of enzymatic phenotypes 191
Cystalysin: an example of the catalytic versatility of pyridoxal 5'-phosphate dependent enzymes 189
The N-terminal extension is essential for the formation of the active dimeric structure of liver peroxisomal alanine:glyoxylate aminotransferase 188
Phosphorylation of pyridoxal 5'-phosphate enzymes: an intriguing and neglected topic 188
Aromatic amino acid methyl ester analogs form quinonoidal species with Dopa decarboxylase 187
Behavior of fluorinated analogs of L-(3,4-dihydroxyphenyl)alanine and L-threo-(3,4-dihydroxyphenyl)serine as substrates for Dopa decarboxylase 185
Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli 185
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: Glyoxylate aminotransferase and the F152I mutation 181
An affinity labeling reagent for pyridoxal phosphate dependent enzymes 179
Alpha5 pyridoxalacetic acid and alpha5 pyridoxyl-L-phenylalanine acetic acid: their action on some B6-dependent enzymes 177
Mutation of residues in the coenzyme binding pocket of Dopa decarboxylase: effects on catalytic properties 175
Dopa decarboxylase: the pig kidney enzyme primary structure and relationship to other amino acid decarboxylases 173
Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook 171
Thermodynamic parameters for substrate-coenzyme protein complex formation in b6-dependent enzymes 168
New insights emerging from recent investigations on human group II pyridoxal 5'-phosphate Decarboxylases 168
R180T variant of δ-ornithine aminotransferase associated with gyrate atrophy: biochemical, computational, X-RAY and NMR studies provide insight into its catalytic features 168
Molecular insight into the synergism between the minor allele of human liver peroxisomal alanine: glyoxylate aminotransferase and the f152i mutation 167
[Preparation and properties of the beta-Hp-Hb complex] 166
Deficit of human ornithine aminotransferase in gyrate atrophy: Molecular, cellular, and clinical aspects 166
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 164
Molecular and cellular basis of ornithine δ-aminotransferase deficiency caused by the V332M mutation associated with gyrate atrophy of the choroid and retina 164
Identification by Virtual Screening and In Vitro Testing of Human DOPA Decarboxylase Inhibitors 164
Pig kidney dopa decarboxylase: inactivation by iodoacetamide and sequence of the carboxyamidomethylcysteine-containing peptide 163
Cloning and expression of pig kidney dopa decarboxylase: comparison of the naturally occurring and recombinant enzymes 163
[Binding of pyridoxyl derivatives to apoaspartate transaminase from swine hearts] 162
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes 161
[Inhibition of APO-DOPA-decarboxylase by phosphopyridoxyl-amino acids] 160
[Action of pyridoxyl-glutamic acid on transaminases] 160
Site-directed mutagenesis provides insight into racemization of alanine catlayzed by "Treponema denticola" cystalysin 160
[Binding of phosphopyridoxyl derivatives to apoaspartate aminotransferase from wheat germ] 159
Crystallization and preliminary X-ray analysis of pig kidney DOPA decarboxylase 159
[Preliminary studies of apo-tyrosine decarboxylase inhibitors] 157
Structural and functional aspects of the active site in aspartate aminotransferase 157
An abnormal reaction occurring in the presence of L-aromatic aminoacid decarboxylase 157
[Separation of pyridoxal phosphate dependent enzymes by means of carboxymethylcellulose hydrazide] 156
A new assay for DOPA decarboxylase activity 155
Stereospecificity of sodium borohydride reduction of pig kidney dopa decarboxylase 155
Spectroscopic and kinetic analyses reveal the pyridoxal 5'-phosphate binding mode and the catalytic features of Treponema denticola cystalysin 155
[Interaction of dopa decarboxylase from swine kidney with thiosemicarbazone] 154
Biochemical and bioinformatic studies of mutations of residues at the monomer-monomer interface of human ornithine aminotransferase leading to gyrate atrophy of choroid and retina 153
A novel compound heterozygous genotype associated with aromatic amino acid decarboxylase deficiency: Clinical aspects and biochemical studies 153
Dopa decarboxylase 152
Mutation of cysteine 111 in dopa decarboxylase leads to active site perturbation 151
Tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex: a novel catecholaminergic group? 150
Insights into the mechanism of oxidative deamination catalyzed by Dopa decarboxylase 148
Heterozygosis in aromatic amino acid decarboxylase deficiency: Evidence for a positive interallelic complementation between R347Q and R358H mutations 147
[Study of the inhibition of the 3'-nucleotidase of the wheat germ by 5'-nucleotides] 146
[Effect of pH on the interaction of 3'-nucleotidase from wheat germ with 5'-phosphate nucleotides] 146
[Effect of Mg++ ion on 5-nucleotidase activity] 145
Lysine 238 is an essential residue for alfa, beta- elimination catalyzed by "Treponema denticola" cystalysin 144
DISSOCIATION, UNFOLDING AND REFOLDING TRIALS OF PIG KIDNEY 3,4-DIHYDROXYPHENYLALANINE (DOPA) DECARBOXYLASE 143
Dopaminergic and noradrenergic sympathetic nerves of the dog have different DOPA decarboxylase activities 142
Reactions of DOPA (3,4-dihydroxyphenylalanine) decarboxylase with DOPA 141
Aromatic L-amino acid decarboxylase. Immunoreactive cells in the tuberal of the carboxyamidomethylcysteine 140
Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. 140
[Preliminary studies on inhibitors of apo-tyrosine transaminase] 139
Time-resolved extrinsic fluorescence of aromatic-L-amino-acid decarboxylase 139
Interaction of aromatic amino acids in D and L forms with 3,4-dihydroxyphenylalanine decarboxylase from pig kidney 138
Pig kidney 3,4-dihydroxyphenylalanine (dopa) decarboxylase. Primary structure and relationships to other amino acid decarboxylases 137
Mechanism-based inactivation of dopa decarboxylase by serotonin 137
Probing the role of Tyr 64 of Treponema denticola cystalysin by site-directed mutagenesis and kinetic studies 137
The binding of coenzymes and analogues of the substrate-coenzyme complex to tyrosine aminotransferase 134
The binding of nucleotides to 3'-nucleotidase from wheat germ 134
Purification and characterization of rat-liver 3,4-dihydroxyphenylalanine decarboxylase 133
Treponema denticola cystalysin catalyzes beta-desulfination of L-cysteine sulfinic acid and beta-decarboxylation of L-aspartate and oxalacetate 133
Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency. 133
The steady state kinetics of tyrosine decarboxylase from Streptococcus faecalis 132
Reaction specificity of native and nicked 3,4-dihydroxyphenylalanine decarboxylase 132
Dopa decarboxylase 131
The binding of the coenzyme pyridoxal 5'-phosphate and analogues of the substrate-coenzyme complex to tyrosine decarboxylase 130
The use of 4'-N-(2,4-dinitro-5-fluorophenyl)-pyridoxamine 5'-phosphate 129
Pig kidney dopa decarboxylase. Structure and function 128
Spectral properties of the coenzyme bound to dopa decarboxylase from pig kidney 127
Characterization of DOPA decarboxylase mRNA in rat pheochromocytoma 126
Ornithine and glutamate decarboxylases catalyse an oxidative deamination of their alpha-methyl substrates 126
Reaction and substrate specificity of pig kidney Dopa decarboxylase under aerobic and anaerobic conditions 126
Reactions of human liver peroxisomal alanine:glyoxylate aminotransferase with beta-chloro-L-alanine and L-cysteine: spectroscopic and kinetic analysis 126
Treponema denticola cystalysin exhibits a significant alanine racemase activity accompanied by transamination: mechanistic implications 125
Multiple roles of the active site lysine of Dopa decarboxylase 125
Totale 16.847
Categoria #
all - tutte 66.697
article - articoli 63.203
book - libri 0
conference - conferenze 514
curatela - curatele 0
other - altro 478
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.502
Totale 133.394


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022571 0 0 0 45 22 20 12 56 39 19 72 286
2022/20231.973 167 154 185 345 212 432 32 122 226 13 59 26
2023/2024776 42 80 62 188 58 76 25 41 3 22 126 53
2024/20252.545 199 152 38 442 124 43 129 121 398 173 234 492
2025/20267.049 569 322 602 965 1.644 456 809 384 621 428 124 125
2026/20271.368 91 212 294 771 0 0 0 0 0 0 0 0
Totale 20.362